Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Predictive Model for Personalized Therapeutic Interventions in Non-small Cell Lung Cancer.

IEEE journal of biomedical and health informatics - 1 Jan 2016

Kureshi Nelofar, Abidi Syed Sibte Raza, Blouin Christian

Abstract excerpt

Non-small cell lung cancer (NSCLC) constitutes the most common type of lung cancer and is frequently diagnosed at advanced stages. Clinical studies have shown that molecular targeted therapies increase survival and improve quality of life in patients. Nevertheless, the realization of personalized therapies for NSCLC faces a number of challenges including the integration of clinical and genetic data and a lack of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Data Mining

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Factual

Share to Decision Trees

Share to ErbB Receptors

Share to Pattern Recognition, Automated

Share to Precision Medicine

Share to Support Vector Machine

Source

Identifiers

PMID: 25494516
DOI: 10.1109/JBHI.2014.2377517

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Predictive Model for Personalized Therapeutic Interventions in Non-small Cell Lung Cancer.PMID 25494516Read ↗

Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutationSemantic proximity Read ↗

Predictions of Targeted Gene Therapy Treatment Success in Patients with Non-Small Cell Lung CancerSemantic proximity Read ↗

Efficient 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based machine learning model for predicting epidermal growth factor receptor mutations in non-small cell lung cancer.Semantic proximity Read ↗

Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patients.Semantic proximity Read ↗

Predictive models for patients with lung carcinomas to identify EGFR mutation status via an artificial neural network based on multiple clinical information.Semantic proximity Read ↗

Machine learning based personalized drug response prediction for lung cancer patients.Semantic proximity Read ↗

Applications of Machine Learning to Predict Cisplatin Resistance in Lung CancerSemantic proximity Read ↗

Applications of Machine Learning to Predict Cisplatin Resistance in Lung CancerSemantic proximity Read ↗

Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation.Semantic proximity Read ↗

Early detection of non-small cell lung cancer using electronic health record dataSemantic proximity Read ↗

Extensive prediction of drug response in mutation-subtype-specific LUAD with machine learning approach.Semantic proximity Read ↗

Predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients through logistic regression: a model incorporating clinical characteristics, computed tomography (CT) imaging features, and tumor marker levels.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.